Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015

por Santerre Henriksen, Anne, Smart, Jennifer I, Hamed, Kamal
Publicado 2018

622. Population Pharmacokinetic Analysis and Probability of Target Attainment Simulations of Pivmecillinam for the Treatment of Uncomplicated Urinary Tract Infection

por Santerre Henriksen, Anne Laurence, Lagraauw, Maxime, Prohn, Marita, Lindbom, Lars
Publicado 2022

In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France

por Naas, Thierry, Lina, Gerard, Santerre Henriksen, Anne, Longshaw, Christopher, Jehl, Francois
Publicado 2021

Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance

por Longshaw, Christopher M, Santerre Henriksen, Anne, Slover, Christine, Yamano, Yoshinori, Karas, J Andreas
Publicado 2022

Evidence for Efficacy of Cefiderocol against OXA-48-Containing Isolates from the APEKS-NP and CREDIBLE-CR Trials

por Longshaw, Christopher, Roger, Echols, Santerre Henriksen, Anne, Baba, Takamichi, Nguyen, Sean, Yamano, Yoshinori
Publicado 2022

Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials

por Scheeren, Thomas W. L., Welte, Tobias, Saulay, Mikael, Engelhardt, Marc, Santerre-Henriksen, Anne, Hamed, Kamal
Publicado 2019

In vitro activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016–19)

por Canton, Rafael, Hamed, Kamal, Wiktorowicz, Tatiana, Redder, Nowel, Jemmely, Noelle, Quevedo, Juan, Santerre Henriksen, Anne
Publicado 2022

660. In vitro activity of cefiderocol against difficult-to-treat resistance European Gram-negative bacterial pathogens from the multi-national sentinel surveillance study, SENTRY i...

por Santerre Henriksen, Anne Laurence, Longshaw, Christopher M, Shortridge, Dee, Streit, Jennifer M, Takemura, Miki, Yamano, Yoshinori
Publicado 2022

Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic

por Giannella, Maddalena, Verardi, Stefano, Karas, Andreas, Abdel Hadi, Hasania, Dupont, Hervé, Soriano, Alex, Santerre Henriksen, Anne, Cooper, Andrew, Falcone, Marco
Publicado 2023

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

por Andes, David R., Ghannoum, Mahmoud A., Mukherjee, Pranab K., Kovanda, Laura L., Lu, Qiaoyang, Jones, Mark E., Santerre Henriksen, Anne, Lademacher, Christopher, Hope, William W.
Publicado 2018